Equasens

Acquisition of a majority stake in DIGIPHARMACIE

Villers-lès-Nancy, 2 January 2024 - 6:00 p.m. (CET)

PRESS RELEASE

Acquisition of a majority stake in DIGIPHARMACIE,
An expert in digital and invoice management solutions for pharmacies

• With this acquisition, Equasens Group:
  • Strengthens its offering of solutions for healthcare professionals and consolidates its position as a leading European provider of digital healthcare solutions.
  • Addresses the growing demand for digital invoicing solutions following the introduction of new obligations in France.
  • Gives pharmacists more time to devote to their patients in a context characterised by increasing difficulties in recruitment in France and Europe.

Equasens Group, a leading healthcare software publisher (Euronext Paris - Compartment A - ISIN: FR 0012882389 - Ticker EQS) today announces its acquisition of a 70% majority stake in the start-up DIGIPHARMACIE.

An innovative and profitable young company

Based in the Paris region and created in 2019, DIGIPHARMACIE is a pure player in digital invoicing solutions for pharmacies. As a provider of SaaS (Software as a Service) solutions for pharmacies, the DNA of this French start-up, led by Yonathan BLAJMAN, David CHALOM and Jonathan FITOUSSI, includes a significant technological component by enabling pharmacies to automatically collect, centralise and store supplier invoices and using artificial intelligence to digitise and structure data flows to the applications used by their external accountants. DIGIPHARMACIE's ready-to-deploy offering also addresses the needs of the pharmaceutical industry. As such, it already complies with the obligation requiring all invoices to be sent and received electronically by 1 September 2026.

With an installed base of already nearly 70% of French pharmacies (13,000 pharmacy customers), nearly 300 accounting firms, including major national groups, and an agreement with nearly 80% of pharmacy groups, DIGIPHARMACIE processes more than 1 million invoices each month on its platform.

Reflecting its achievements, in 2023 DIGIPHARMACIE was a recipient of the Prix de l'Innovation PharmagoraPlus (PharmagoraPlus Innovation Award).

"This acquisition of a majority stake in Digipharmacie provides yet another confirmation of the Equasens Group's commitment to supporting innovative start-ups,” commented Denis SUPPLISSON, Chief Executive Officer of Equasens. "DIGIPHARMACIE has been profitable since its creation in 2019 and has very quickly become the leader in its market. As a result of this acquisition, we are now able to offer pharmacists and their chartered accountants a complete and disruptive solution to meet their needs in the area of electronic invoicing."